However, EPAS1 has also been described as tumor suppressive in various other cancer types including neuroblastoma, colon cancer, and hepatocellular carcinoma, and shown to reduce tumor growth and improve patient outcomes when overexpressed [45,46,47,48]. This evidence concerns the gene EPAS1 and malignant colon neoplasm.